Healthcare -
Biotechnology - NASDAQ - US
$ 1.95
0 %
$ 409 M
Market Cap
-1.26
P/E
ALLO - OTHER FINANCING ACTIVITIES
Other Financing Activities ALLO - Allogene Therapeutics, Inc.
4.58 M
LAST VALUE
-38.11%
2 YEAR CAGR
-65.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR